Retatrutide + Tirzepatide 20MG + 40MG (60MG Total)

Research Profile

Retatrutide + Tirzepatide is a research blend combining two investigational peptide compounds commonly studied in incretin and metabolic receptor pathway models. This blend is intended for controlled laboratory research involving multi-peptide signaling comparison.

Study Context

Retatrutide is commonly studied for multi-receptor pathway activity, while Tirzepatide is studied as a dual GIP and GLP-1 receptor agonist. This blend may be used in research settings focused on comparative receptor signaling, peptide interaction models, and incretin-pathway investigation.

Research Interest

Researchers commonly study this blend for:

• Multi-peptide receptor pathway research
• Incretin signaling comparison
• GLP-1 and GIP pathway models
• Glucagon-related receptor research
• Combination peptide study design

Product Details

Retatrutide + Tirzepatide Blend is supplied as a lyophilized research material in a sterile, sealed vial for controlled laboratory research. Bacteriostatic water is necessary for reconstitution but is not included.

Lab Use Notice

For research use only. Not for human or animal consumption.